Discontinuation report POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR
Report ID | 128947 |
Drug Identification Number | 00786306 |
Brand name | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR |
Common or Proper name | 40 MEQ Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE SODIUM CHLORIDE POTASSIUM CHLORIDE |
Strength(s) | 5G 900MG 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000mL, 14 bags/case |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-02-01 |
Actual discontinuation date | 2021-02-01 |
Remaining supply date | 2021-02-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Baxter will continue to supply 2B2454X until the expected stock out of February 1st, 2021 |
Company comments | We have identified four alternative codes for your consideration: JB1674, JB1434, JB1264, and JB1984 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-26 | English | Compare |
v2 | 2020-11-26 | French | Compare |
v3 | 2021-02-02 | English | Compare |
Showing 1 to 3 of 3